1Feldman PL, James MK, Grackeen MF, et al. Design, synthesis,and pharmacological evaluation of uhrashort to Jong-acting opioid analgesics. J Med Chem, 1991,34:2202-2208.
2Kapila A,Glass PSA,Jaeobs JR,et al. Measured eontextsensitive half times of remifentanil and alfentanil. Anesthesiology,1995,83:968-975.
1Feldman PL, James MK, Brackeen MF,et al. Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J Med Chem, 1991,34 : 2202-2208.
2Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opiold: remifentanil (GI87084B). Anesth Analg, 1993, 77: 1031-1040.
3Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology,1995,83,968-975.
4Hoke JF, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology, 1997,87:533-541.
5Camu F, Royston D. Inpatient experience with remifentanil. Anesth Analg, 1999,89(Suppl 4): 15-21.
6uyk J, Mertens MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology, 1997, 87:1549-1562.
7Hoymork SC,Raeder J, Grimsmo B, et al. Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesthesiol Scand,2000,44:1138-1144.
